Decoding the central nervous system through the eye.
EyeTech is the technology holding company that transforms physiological data into strategic decisions.
We are building an ecosystem of B2B solutions powered by Biometrics and AI, which predict behaviors, disorders, and alert states to redefine the future of work and society.
Deep Tech innovation that connects physiology with profitability.
EyeTech is a research and development (R&D) company focused on the intersection of ocular biometrics, artificial intelligence, and the central nervous system (CNS). Our patented technology analyzes ocular responses to predict behavior and diagnose neurocognitive disorders in an objective and non-invasive manner.
EyeTech’s models are based on internationally validated scientific research.
Our first commercial success story is FitWork, a B2B solution designed to assess work readiness.
Our vision goes even further: we are building the ultimate ecosystem of technological tools focused on corporate productivity and safety on a global scale.
The Global Problem We Are Solving
The lack of objective data on human cognitive status costs industries billions of dollars every year.
21.7%
Positive
in drugs and alcohol
Global Partners Chile 2022
More than
145,000
Accidents
Annual serious accidents in industrial operations, preventable with predictive technology.
Source: SUSESO Chile 2024
100%
Data Driven
Need to move from reactive management to an objective data model.
Peter Drucker: "You can't manage what you can't measure."
EyeTech Core: Patented intellectual property
Our competitive advantage is based on a three-layer architecture, applicable to multiple industries and future spin-offs.
Hardware Agnostic
-
Advanced fast-capture infrared sensors that operate non-invasively (15 seconds) and can be integrated into mobile devices, totems and, in the future, augmented reality (VR/AR) glasses.
Proprietary AI Algorithms
-
Deep neural networks trained with the most robust pupillary/iris behavior database on the market, capable of predicting CNS alterations associated with fatigue, stress, or substances.
Cloud Platform
-
A cloud ecosystem that consolidates information into dashboards for decision-making at all corporate levels.
_e.png)
How do we transform a biomarker into predictive data?
Zero friction is the key to our solutions.
1. High-Precision Capture:
Infrared sensors isolate the iris and pupil spectrum regardless of environmental conditions.
2. Robust Verification:
Biometric identity algorithms prevent impersonation, ensuring data integrity.
3. CNS Evaluation (Edge Computing):
Artificial intelligence processes the neuromotor response in real time, detecting alterations or cognitive impairment.
4.Generating Alerts and Insights:
Actionable (predictive) metrics are delivered to customer management systems for mitigation.
immediate and future risks.
.png)
Our Ecosystem and Commercial Roadmap
CURRENT PRODUCT
-
Solution focused on operational safety.
-
Currently implemented under licensing models.
-
In high-risk industries such as mining and transportation.
-
Mitigate critical incidents by measuring job aptitude.
EXPANSION
Wellness & Productivity
-
Platforms under development focused on assessing stress, cognitive load, and fatigue in high-performance corporate work environments.
-
Human Capital Management.
FUTURE
Integration/Automation
-
Licensing of our eye analysis algorithm.
-
Integrations with global hardware manufacturers, human-computer interfaces (HCI), and telemetry systems.
Why EyeTech?
Product-Market Fit Proven
Initial traction and successful technical validation with FitWork in large-scale mining
Zero-Baseline Technology
Unlike the competition, our algorithms do not require a prior user history, allowing for immediate scalability (Plug & Play).
High Barrier to Entry
International scientific validation and proprietary databases, blocking generic competitors.
Global B2B Scalability
Available in high-performance On-Premise or SaaS (Software as a Service) models with standardized hardware implementations.
Contact us
Lead the technological revolution with us.
Are you a member of a Venture Capital fund, a journalist specializing in Deep Tech, or are you looking for R&D partnerships?
Let's talk about the future.